Your email has been successfully added to our mailing list.

×
-0.0137614678899083 -0.0137614678899083 -0.0137614678899083 -0.0183486238532109 -0.0137614678899083 -0.00688073394495406 -0.00688073394495406 -0.0206422018348624
Stock impact report

BeyondSpring’s Lead Asset, Plinabulin, Shows Superior Efficacy Compared to Neulasta for Prevention of Thrombocytopenia Induced by Docetaxel in Phase 2 Trial

BeyondSpring, Inc. - Ordinary Shares (BYSI) 
Last beyondspring, inc. - ordinary shares earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.beyondspringpharma.com
Company Research Source: GlobeNewswire
Data Provide Further Support for Plinabulin’s Superior Product Profile Clinical Data Will be Presented at 2018 IASLC 19th World Conference on Lung Cancer NEW YORK , Sept. 06, 2018 (GLOBE NEWSWIRE) --  BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, will present clinical trial data on its lead asset, Plinabulin, during a poster presentation titled, “Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy-Induced Neutropenia and Thrombocytopenia in NSCLC Patients” at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer. The conference will take place on Sept. 23 through 26, 2018, in Toronto, Canada. The data demonstrated that Plinabulin, a novel, non-G-CSF small molecule in development for the prevention of chemotherapy-induced neutropenia (CIN) and for the treatment of non-small cell lung cancer (NSCLC), mitigated both Show less Read more
Impact Snapshot
Event Time:
BYSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BYSI alerts
Opt-in for
BYSI alerts

from News Quantified
Opt-in for
BYSI alerts

from News Quantified